These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COSMOS HOLDINGS INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Nevada
|
27-0611758
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
141 West Jackson Blvd, Suite
4236, Chicago, Illinois
|
60604
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
Smaller Reporting Company
|
x
|
|
PART I – FINANCIAL INFORMATION
|
|||||
|
Item 1.
|
Financial Statements.
|
F-1 | |||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
3 | |||
|
Item 3.
|
Quantitative and Qualitative Disclosure about Market Risk.
|
7 | |||
|
Item 4.
|
Controls and Procedures.
|
7 | |||
|
PART II – OTHER INFORMATION
|
|||||
|
Item 1.
|
Legal Proceedings.
|
8 | |||
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
8 | |||
|
Item 3.
|
Defaults Upon Senior Securities.
|
8 | |||
|
Item 4.
|
Mine Safety Disclosures.
|
8 | |||
|
Item 5.
|
Other Information.
|
8 | |||
|
Item 6.
|
Exhibits.
|
9 | |||
|
SIGNATURES
|
10 | ||||
|
June 30,
2014
|
December31,
2013
|
|||||||
|
ASSETS
|
||||||||
|
Cash and equivalents
|
$
|
841,028
|
$
|
864,489
|
||||
|
Accounts receivable
|
1,228,050
|
-
|
||||||
|
Prepaid expenses
|
32,698
|
435
|
||||||
|
Other assets
|
2,126
|
2,126
|
||||||
|
TOTAL ASSETS
|
$
|
2,103,902
|
$
|
867,050
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$
|
69,628
|
$
|
530,185
|
||||
|
Unearned revenues
|
-
|
671
|
||||||
|
Salaries payable
|
179,092
|
186,592
|
||||||
|
Notes payable, related party
|
165,000
|
165,000
|
||||||
|
Taxes payable
|
264,271
|
38,286
|
||||||
|
TOTAL CURRENT LIABILITIES
|
$
|
677,991
|
$
|
920,734
|
||||
|
SHAREHOLDERS' EQUITY
|
||||||||
|
Preferred stock, par value $0.001, authorized 100 million shares, none issued and outstanding at June 30, 2014.
|
-
|
-
|
||||||
|
Common stock, par value $0.001, authorized 300 million, 125,585,532 and 125,585,532 issued and outstanding at June 30, 2014 and December 31, 2013, respectively.
|
125,586
|
125,586
|
||||||
|
Additional paid-in capital
|
(427,683
|
)
|
(432,593
|
)
|
||||
|
Accumulated other comprehensive (loss) income
|
(56,495
|
)
|
11,319
|
|||||
|
Retained earnings
|
1,784,503
|
242,004
|
||||||
|
TOTAL SHAREHOLDERS' EQUITY (DEFICIT)
|
1.425,911
|
(53,684
|
)
|
|||||
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$
|
2,103,902
|
$
|
867,050
|
||||
|
Six Months Ended June 30,
|
Three Months Ended June 30,
|
|||||||||||||||
|
2014
|
2013
|
2014
|
2013
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
Revenues
|
$ | 2,015,223 | $ | - | $ | 1,234,167 | $ | - | ||||||||
|
Expenses
|
||||||||||||||||
|
General and administrative expenses
|
241,434 | 493,718 | 168,261 | 493,718 | ||||||||||||
|
Net operating income (loss)
|
1,773,789 | 493,718 | 1,065,906 | 493,718 | ||||||||||||
|
Other income and (expense)
|
||||||||||||||||
|
Interest expense - related party
|
(4,910 | ) | - | (2,469 | ) | - | ||||||||||
|
Total other income and (expense)
|
(4,910 | ) | - | (2,469 | ) | - | ||||||||||
|
Income (loss) before income taxes
|
1,768,879 | (493,718 | ) | 1,063,437 | (493,718 | ) | ||||||||||
|
Income tax expense
|
226,380 | - | 135,154 | - | ||||||||||||
|
Net income (loss)
|
1,542,499 | (493,718 | ) | 928,283 | (493,718 | ) | ||||||||||
|
Other comprehensive income (loss)
|
||||||||||||||||
|
Unrealized foreign currency income (loss)
|
(67,814 | ) | 3,240 | (11,590 | ) | 3,240 | ||||||||||
|
NET COMPREHENSIVE INCOME (LOSS)
|
$ | 1,474,685 | $ | (490,478 | ) | $ | 916,693 | $ | (490,478 | ) | ||||||
|
Net income (loss) per share – basic
|
$ | 0.01 | $ | (0.00 | ) | $ | 0.01 | $ | (0.00 | ) | ||||||
|
Net income (loss) per share – dilutive
|
$ | 0.01 | $ | (0.00 | ) | $ | 0.01 | $ | (0.00 | ) | ||||||
|
Weighted average number of shares outstanding – basic
|
125,585,532 | 100,000,000 | 125,585,532 | 100,000,000 | ||||||||||||
|
Weighted average number of shares outstanding – dilutive
|
125, 804,894 | 100,000,000 | 125, 804,113 | 100,000,000 | ||||||||||||
|
Common Stock, Par Value $0.001
|
Additional
Paid In
|
Other Comprehensive
|
Retained
|
Total
Shareholders'
|
||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Income (loss)
|
Earnings
|
Equity (Deficit)
|
|||||||||||||||||||
|
Balances, December 31, 2013
|
125,585,532
|
$ |
125,586
|
$ |
(432,593
|
)
|
$ |
11,319
|
$ |
242,004
|
$ |
(53,684
|
)
|
|||||||||||
|
Imputed interest
|
-
|
-
|
4,910
|
-
|
-
|
4,910
|
||||||||||||||||||
|
Foreign currency translation effect
|
-
|
-
|
-
|
|
(67,814
|
)
|
-
|
(67,814
|
)
|
|||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
1,542,499
|
1,542,499
|
||||||||||||||||||
|
Balances,
June 30, 2014
|
125,585,532
|
$
|
125,586
|
$
|
(427,683
|
)
|
$
|
(56,495
|
)
|
$
|
1,784,503
|
$
|
1,425,911
|
|||||||||||
|
Six Months Ended
June 30,
|
||||||||
|
2014
|
2013
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
|
Net income (loss)
|
$
|
1,542,499
|
$
|
(493,718
|
)
|
|||
|
Adjustments to reconcile net income (loss) with cash used in operations:
|
||||||||
|
Imputed interest
|
4,910
|
-
|
||||||
|
Change in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(1,228,050
|
)
|
-
|
|||||
|
Prepaid expenses
|
(32,263
|
)
|
-
|
|||||
|
Accounts payable and accrued liabilities
|
(468,057
|
)
|
489,075
|
|||||
|
Taxes payable
|
225,985
|
-
|
||||||
|
Deferred revenue
|
(671
|
)
|
-
|
|||||
|
Net cash provided by / (used in) operating activities
|
44,353
|
(4,643
|
)
|
|||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Expenses paid by shareholders
|
-
|
1,403
|
||||||
|
Net cash provided by / (used in) financing activities
|
-
|
1.403
|
||||||
|
Foreign currency translation effect
|
(67,814
|
)
|
3,240
|
|||||
|
NET DECREASE IN CASH
|
(23,461
|
)
|
-
|
|||||
|
Cash at beginning of period
|
864,489
|
-
|
||||||
|
Cash at end of period
|
$
|
841,028
|
$
|
-
|
||||
|
SUPPLEMENTAL DISCLOSURES
|
||||||||
|
Cash paid for interest
|
$
|
-
|
$
|
-
|
||||
|
Cash paid for income taxes
|
-
|
-
|
||||||
|
Six months ended
|
Three months ended
|
|||||||||||||||
|
June 30,
2014
|
June 30,
2013
|
June 30,
2014
|
June 30,
2013
|
|||||||||||||
|
Net income (loss)
|
$ | 1,542,499 | - | $ | 928,283 | $ | - | |||||||||
|
Weighted average common shares outstanding - basic
|
125,585,532 | 100,000,000 | 125,585,532 | 100,000,000 | ||||||||||||
|
Option awards
|
219,362 | - | 218,581 | - | ||||||||||||
|
Weighted average common shares outstanding - dilutive
|
125,804,894 | 100,000,000 | 125,804, 113 | 100,000,000 | ||||||||||||
|
Net income (loss) per share - basic and diluted
|
0.01 | (0.00 | ) | 0.01 | (0.00 | ) | ||||||||||
|
●
|
Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
|
|
●
|
Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
|
|
Exhibit No.
|
Document Description
|
|
|
31.1
|
Certification of CEO/CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification of CEO/CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
| Cosmos Holdings Inc. | |||
|
Date: August 11, 2014
|
By:
|
/s/ Dimitrios Goulielmos
|
|
|
Dimitrios Goulielmos
|
|||
|
Principal Executive Officer, Acting Principal Financial Officer and Acting Principal Accounting Officer and Director
|
|||
|
Exhibit No.
|
Document Description
|
|
|
31.1
|
Certification of CEO/CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification of CEO/CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|